JPMorgan analyst Brian Essex raised the price target on Cellebrite (NASDAQ: CLBT) to $28.00 (from $24.00) while maintaining a Overweight ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE